ATO – Non Anaemic Iron Deficiency and Treatment Outcomes after Colorectal Cancer Surgery

Not Applicable

Completed

• Conditions: Iron deficiency; Colorectal cancer; Cancer - Bowel - Back passage (rectum) or large bowel (colon); Surgery - Other surgery; Blood - Other blood disorders; Metabolic and Endocrine - Other metabolic disorders

• Registration Number: ACTRN12618001997246
• Lead Sponsor: Department of Critical Care, University of Melbourne

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-12-12
• Study Completion: 2023-04-24
• Last Update Posted: 1 May 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 422

Inclusion Criteria

Patient scheduled to undergo major elective surgery for colorectal cancer (laparoscopic or open colectomy, anterior resection or abdominoperineal resection).

Exclusion Criteria

Pregnancy
Age < 18 years
Iron supplementation (oral or parenteral) or EPO therapy received or planned between baseline preoperative blood tests and operation
Haemoglobinopathy (thalassaemia or sickle cell)
Bone marrow disease or haemochromatosis
End-stage renal failure requiring dialysis
Pre-operative anaemia (female: Hb < 120g/L, male: Hb < 130 g/L)
Pelvic exenteration or secondary surgical procedure (i.e. bowel resection AND liver resection during the same surgical procedure)

Study & Design

• Study Type: Observational
• Study Design: Not specified